For Immediate Release
Oak Brook, IL (July 27, 2022) – SLAS journals saw a substantial increase in article submissions during the global COVID-19 pandemic. In 2020, SLAS Discovery and SLAS Technology published special issues featuring original research related to combatting the COVID-19 virus. As article submissions increased, so did the citations over the two-year period that would influence the 2021 Impact Factors.
Specified in the latest Journal Citations Report (JCR) from Clarivate, SLAS Discovery achieved an Impact Factor of 3.341 for 2021 increasing from 2020’s 2.918 by nearly 15%. SLAS Technology for 2021 is now 2.813, representing a minor decrease from the 2020 Impact Factor.
“A big driver of the growth we saw this year was high citation rates for our 2020 papers,” says SLAS Discovery Editor-in-Chief Robert M. Campbell, Ph.D., regarding the SLAS Discovery increased Impact Factor. “This is great to see, as those papers will continue to positively impact ongoing scientific research but also our Impact Factors next year. Our editors have put a lot of energy into curating compelling Special Issues that distill the latest on rapidly advancing topics into a single focused issue. Our Special Issues such as ‘Drug Discovery Targeting COVID-19’ and ‘Advances in Protein Degradation' – have generated significant attention and citations for the contributing authors.”
“While SLAS Technology’s Impact Factor experienced a slight drop this year, this was largely due to an unprecedented increase in accepted publications in 2020,” says SLAS Technology Editor-in-Chief Edward Kai-Hua Chow, Ph.D. “As SLAS Technology continues to grow, we are excited to continue to bring advances in life science and biomedical technology to an increasingly larger audience. Our recent move to Open Access should accelerate this growth by increasing access to SLAS Technology research.”
Since transitioning to Open Access publishing for SLAS journals, contributing authors have experienced a significant increase in the reach of their published work. To continue with the success of the publications, the editors of SLAS Discovery and SLAS Technology are offering article processing charge (APC) waivers for review article submissions to ensure research accessibility and enhance citation potential for its authors.
Authors seeking publication can view the current call for papers listing for upcoming issues of SLAS Discovery and SLAS Technology.
SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
SLAS Discovery: Advancing the Science of Drug Discovery, 2021 Impact Factor 3.341. Editor-in-Chief Robert M. Campbell, Ph.D., Twentyeight-Seven Therapeutics, Boston, MA (USA)
SLAS Technology: Translating Life Sciences Innovation, 2021 Impact Factor 2.813. Editor-in-Chief Edward Kai-Hua Chow, Ph.D., National University of Singapore (Singapore).
Director of Marketing Communications
Telephone: +1.630.256.7527, ext. 103